RANK/RANKL is expressed in many tumor tissues (39), and many breast cancer patients show abnormally high levels of RANKL expression in primary lesions, and a positive correlation with the incidence of bone metastases (47). This evidence concerns the gene TNFSF11 and breast carcinoma.